Stay updated on NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial page.

Latest updates to the NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page history shows a new revision entry (v3.3.4) and removal of revision v3.3.3, indicating a small administrative update to the record history; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry Revision: v3.3.3 was added to the record history, while the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check60 days agoChange DetectedRevision updates to the ClinicalTrials.gov page: v3.3.2 added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedThe government funding lapse notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check81 days agoChange DetectedThe new screenshot shows updates in the study record history, including status entries and quality-control notes; no core study content or current trial details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check110 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference12%

Stay in the know with updates to NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial page.